Gaudium IVF Posts 47.56% Revenue Growth to ₹104.36 Cr for FY26

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorRiya Kapoor|Published at:
Gaudium IVF Posts 47.56% Revenue Growth to ₹104.36 Cr for FY26
Overview

Gaudium IVF and Women Health Ltd reported a 47.56% year-on-year revenue growth for FY26, reaching ₹104.36 crore. The company also detailed its post-IPO expansion plans and AI integration, though EBITDA margins saw a slight contraction.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Gaudium IVF Reports Robust 47.56% Revenue Growth to ₹104.36 Crore in FY26

Revenue from operations for FY26 stands at ₹104.36 crore, a 47.56% increase from ₹70.72 crore in FY25.
EBITDA (Ex. Other Income) grew 31.69% to ₹37.70 crore in FY26.

Reader Takeaway: Strong revenue growth and AI-driven success rates are positives, while margin compression and IPO dilution need monitoring.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.